Amlodipine Besylate Tablet
Product Images NDC 71610-888

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-888). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0888 15)

Amlodipine Besylate 5 mg tablets packaging label from Aphena Pharma Solutions - Tennessee, LLC. The label indicates a supply of 15 tablets with the NDC number 71610-888-15. It includes storage instructions to maintain between 20-25 degrees Celsius and keep out of reach of children. The product is for oral use and labeled as prescription only.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical Structure (Image 1)

Chemical structure of Amlodipine Besylate, a molecule showing its specific atomic arrangement and the chemical formula C20H25ClN2O5.*

FDA Label Image

\\client\x$\products\amlodipine Besylate Tabs (076846)\submissions\2017-11-29 Cbe-0 (AJK\Working\INSERT\Image Files\AmlodipineTab-fig01.jpg)

A Kaplan-Meier survival curve comparing event rates over time in months between Amlodipine and placebo groups. The graph shows lower event rates for Amlodipine compared to placebo across the study duration, with risk numbers at various time points and statistical data including P-value, hazard ratio, and confidence interval noted on the chart.*

FDA Label Image

\\client\x$\products\amlodipine Besylate Tabs (076846)\submissions\2017-11-29 Cbe-0 (AJK\Working\INSERT\Image Files\AmlodipineTab-fig02.jpg)

A forest plot graph displaying hazard ratios with 95% confidence intervals for subgroups of patients taking Amlodipine Besylate compared to placebo. It includes categories such as overall patients, age groups, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata, with data points favoring either Amlodipine or placebo along a horizontal axis ranging from 0.0 to 2.0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.